Skip to main content
Premium Trial:

Request an Annual Quote

SRA Nets $15.5M NIEHS Grant

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – SRA International has won a grant that will total up to $15.5 million from the National Institutes of Health to provide biological research and other related services for studies in the National Toxicology Program.

SRA will use the funds from the National Institute of Environmental Health Sciences for up to five years to provide statistical, mathematical, bioinformatics, and computational expertise and support for the NTP, which is an interagency program that uses molecular biology and toxicology to evaluate agents of public health concern.

SRA, which has been working with NIEHS for over two decades, said it will continue supporting the NTP by designing and analyzing data from genomics research, toxicology bioassays, human studies, and basic biological research.

"Over the years, our work has evolved to require higher levels of expertise and support, and we hope to continue to support NIEHS in even more innovative ways," SRA VP Paul Nedzbala said in a statement.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.